$0.76
-0.05 | -6.21%
-0.05 | -6.21%
Today's Range:
0.75 -
0.84
SVNT Avg. Daily Volume:
1,153,500
05/30/12 - 3:00 PM ET
TRADE NOW
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 0.81 |
| 52 Week High | 8.08 |
| 52 Week Low | 0.75 |
| Avg. Daily Vol. (Mil) | 1.15 |
| Beta (3 year) | 1.42 |
| Share Related Items | |
| Mkt Cap (Mil) | 58.66 |
| Shares Out (Mil) | 72.39 |
| Float (Mil) | 58.42 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 5.60 |
| Current Ratio | 6.30 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | n.a. |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 4.97 |
| Price/Book | 0.00 |
| Price/Cash Flow | -0.50 |
| Per Share Data | |
| Earnings | -1.75 |
| Sales | 0.16 |
| Book Value | 0.00 |
| Cash Flow | -1.66 |
| Business Summary | |
|---|---|
| Savient Pharmaceuticals, Inc. is focused on developing and marketing pharmaceutical products that target unmet medical needs in both niche and broader specialty markets. It is currently developing one product: KRYSTEXXA. | |
| General Information | |
| One Tower Center
14th Floor East Brunswick, NJ 08816 |
|
| www.savientpharma.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 173 | |
| CEO: Mr. David Y. Norton | |
| Short Interest | |
| Current Month (Mil) | 26.64 |
| Previous Month (Mil) | 27.99 |
| Short Interest Ratio (Days) | 18.30 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -76.60 |
| Return on Investments | -90.00 |
| Profitability | |
| Gross Margin | 30.00 |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,423.99 | 1,314.92 | 2,839.67 | 16.25 |
Oil *
103.22
|
|
DOWN
156.70 |
DOWN
17.50 |
DOWN
31.32 |
DOWN
1.06 |
10 Yr
1.62%
SPDR Gold
152.09
|
|
-1.25%
|
-1.31%
|
-1.09%
|
-6.12%
|
Data delayed 20 minutes |
Connect with TheStreet